Skip to main content

You are here


Why are we there?

  • Healthcare exclusion
  • Endemic/epidemic disease

Our Work


Extensively drug-resistant tuberculosis (XDR-TB)

  • The paediatric TB programme supported by Médecins Sans Frontières at Dushanbe hospital provides TB diagnosis and treatment for young people aged 18 or under.
  • Children with TB receive appropriate treatment on an outpatient basis whenever possible, with nutritional and psychosocial support to help them adhere to their arduous regimens.
  • In 2014, drug compounding (combining drugs to create a formulation particular to a patient’s needs) was introduced to make paediatric formulations of drugs for MDR-TB.
  • The health ministry, in partnership with Médecins Sans Frontières, diagnoses and treats patients’ family members and Médecins Sans Frontières searches for individual solutions for people who live far from the hospital.
  • Médecins Sans Frontières is also working to eliminate the stigma of TB and to facilitate children’s return to school.
  • Until now, only Médecins Sans Frontières was providing XDR-TB treatment in Tajikistan, but discussions with the Global Fund and the United Nations Development Programme have been successful and treatment provision is beginning to expand.
  • The Paediatric TB Protocol developed by Médecins Sans Frontières has been adopted as the national guideline.


Kala azar

  • In May, Médecins Sans Frontières completed a response to the 2013 outbreak of kala azar (visceral leishmaniasis) in Tajikistan.
  • Médecins Sans Frontières trained health ministry professionals including doctors, nurses, epidemiologists and laboratory technicians in seven locations, and worked on national guidelines for disease management. 


For the latest news on where we work visit:

Médecins Sans Frontières has been working in the country since 1997 and at the end of 2014, Médecins Sans Frontières had 67 staff in Tajikistan.